17 insiders reported 243 Form 4 transactions for Travere Therapeutics, Inc. (TVTX) over the past 18 months (most recent 2026-09-17). Recent activity: REED ELIZABETH E (Chief Legal Officer and GC) Buy 37,500 shares, Inrig Jula (EVP, Head of R&D & CMO) Sell 17,284 shares, Dube Eric M (CHIEF EXECUTIVE OFFICER) Buy 95,666 shares, Heerma Peter (EVP, CHIEF COMMERCIAL OFFICER) Buy 39,283 shares, Calvin Sandra (SVP, CHIEF ACCOUNTING OFFICER) Buy 2,500 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | REED ELIZABETH E | Chief Legal Officer and GC | Buy | 37,500 | $579,750 |
| 2026-09-17 | Inrig Jula | EVP, Head of R&D & CMO | Sell | 17,284 | $1.1M |
| 2026-09-17 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Buy | 95,666 | $2.2M |
| 2026-09-17 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Buy | 39,283 | $1.1M |
| 2026-09-17 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Buy | 2,500 | $68,750 |
| 2026-09-17 | Inrig Jula | EVP, Head of R&D & CMO | Buy | 32,395 | $289,287 |
| 2026-09-17 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Buy | 20,000 | $348,800 |
| 2026-09-17 | ROTE WILLIAM E. | Chief Research Officer | Buy | 39,000 | $984,750 |
| 2026-09-17 | ROTE WILLIAM E. | Chief Research Officer | Buy | 39,650 | $712,114 |
| 2026-09-17 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 63,498 | $3.9M |
| 2026-09-17 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Buy | 1,381 | $30,934 |
| 2026-09-17 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Buy | 1,250 | $28,000 |
| 2026-09-17 | Inrig Jula | EVP, Head of R&D & CMO | Sell | 25,390 | $1.6M |
| 2026-09-17 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 27,473 | $1.7M |
| 2026-09-17 | REED ELIZABETH E | Chief Legal Officer and GC | Sell | 13,874 | $868,965 |
| 2026-09-17 | ROTE WILLIAM E. | Chief Research Officer | Sell | 63,907 | $4.0M |
| 2026-09-17 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 28,796 | $1.8M |
| 2026-09-17 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Buy | 36,526 | $326,177 |
| 2026-09-17 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Buy | 1,625 | $33,248 |
| 2026-09-17 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 71,938 | $4.5M |
| 2026-09-17 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 20,735 | $1.3M |
| 2026-09-17 | REED ELIZABETH E | Chief Legal Officer and GC | Sell | 1,400 | $89,166 |
| 2026-09-17 | ROTE WILLIAM E. | Chief Research Officer | Sell | 29,021 | $1.8M |
| 2026-09-17 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 3,102 | $197,422 |
| 2026-09-17 | REED ELIZABETH E | Chief Legal Officer and GC | Sell | 21,926 | $1.4M |
来源：SEC Form 4 申报文件 · 截至 2026-09-17